Clinical Trials Logo

Clinical Trial Summary

Management of cardiac arrest according to published guidelines has remained largely unchanged for a decade. Thames Valley Air Ambulance provide Critical Care Paramedic and Physician teams who respond to cardiac arrests and offer treatments beyond the scope of ambulance service clinicians. Following a review of practice and appraisal of evidence the investigators developed an additional algorithm for cases of adult medical cardiac arrest with refractory shockable rhythms. This adds to but does not replace the Advanced Life Support algorithm and includes: - Delivering shocks with the LUCAS mechanical CPR device running - After 5 shocks have been delivered placing new pads in the Anterior Posterior (AP) position - Delivering shocks using the TVAA Tempus Pro defibrillator rather than the Ambulance Service defibrillator. This bundle was based on recommendations from ILCOR and the Resus Council (UK) Advanced Life Support manual and was launched in October 2021.


Clinical Trial Description

Study hypothesis An enhanced algorithm for refractory shockable rhythms terminates VF/VT and improves outcomes (ROSC at hospital) in out of hospital cardiac arrest. Study design PICOST Population - adult patients with medical cardiac arrest in refractory shockable rhythms (defined as continuous VF or VT after 5 shocks). Intervention - application of the TVAA enhanced cardiac arrest bundle Comparison - 18 month period before the introduction of the bundle (if the COVID period has significantly different response times than the intervention group then the COVID period will be excluded). Outcome - primary outcome measure is ROSC at hospital (as this represents the success of the pre-hospital phase of resuscitation). Study design - Retrospective observational study using the TVAA HEMSBASE database Timeframe - 18 months of data since the bundle was introduced. Exclusions - traumatic cardiac arrests, cardiac arrests where the VF/VT was recurrent (could be terminated but then restarted) rather than refractory (unable to get the patient out of the shockable rhythm). Refractory VF refers to VF that persists despite shock delivery (i.e. shock-resistant VF). This is distinguished from recurrent VF, which is VF that re-appears after it has been terminated (2). In this study refractory would be defined as continuous VF or VT after 5 shocks. Data set to be collected All data is held within HEMSBASE Age, sex, witnessed arrest, bystander CPR, time from 999 call to TVAA on scene, first rhythm, number of shocks (total in before group; number of shocks pre and post vector change in the after group), outcome (ROSC at any stage; PLE, died on arrival to ED, ROSC in ED). Statistical analysis Statistical support will be sought from the South Central Research Design Service https://www.rds-sc.nihr.ac.uk Fisher's test or Chi square tests may be appropriate. Ethical approval The HRA decision tools indicate that the study does not require REC review. Search strategy Two independent researchers will search HEMSBASE for the intervention period (Oct 21 to April 23) and the control period (19 months prior to Oct 21, excluding the COVID period if response times are significantly different in this period) using the following strategy. HEMSBASE search - Cardiac arrests - Initial rhythm VF or VT - Manual search looking for refractory shockable rhythms (defined as continuous VF or VT after 5 shocks with no change to ROSC or a non shockable rhythm at any stage). This search strategy will deliver a list of cases of refractory shockable rhythms that can then be compared between the two reviewers to ensure all cases are included, any cases where there is not agreement will be adjudicated by a third reviewer. The cases will then be analysed for the data set above and entered into an excel spreadsheet. Data security No patient identifiable data will be exported outside of HEMSBASE. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05926973
Study type Observational
Source Thames Valley Air Ambulance
Contact James Raitt, MBChB
Phone 0300 999 0135
Email james.raitt@tvairambulance.org.uk
Status Recruiting
Phase
Start date May 1, 2023
Completion date September 2023

See also
  Status Clinical Trial Phase
Recruiting NCT06048068 - Removing Surrogates' Uncertainty to Reduce Fear and Anxiety After Cardiac Events N/A
Recruiting NCT05558228 - Accuracy of Doppler Ultrasound Versus Manual Palpation of Pulse in Cardiac Arrest
Completed NCT03685383 - Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation N/A
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Completed NCT04619498 - Effectiveness of an Interactive Cognitive Support Tablet App to Improve the Management of Pediatric Cardiac Arrest N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Withdrawn NCT02352350 - Lactate in Cardiac Arrest N/A
Completed NCT03024021 - Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia
Completed NCT02275234 - Care After Resuscitation
Completed NCT02247947 - Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome
Completed NCT01972087 - Simulation Training to Improve 911 Dispatcher Identification of Cardiac Arrest N/A
Completed NCT01936597 - Prospective Study of 3 Phone Assistance Strategies to Achieve a Continuous Cardiac Massage N/A
Completed NCT01944605 - Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest N/A
Active, not recruiting NCT01239420 - Norwegian Cardio-Respiratory Arrest Study
Completed NCT01191736 - Ultra-Brief Versus Brief Hands Only CPR Video Training With and Without Psychomotor Skill Practice N/A
Completed NCT00880087 - Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial N/A
Completed NCT00878644 - Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial Phase 3
Completed NCT00729794 - Vasopressin, Epinephrine, and Steroids for Cardiac Arrest Phase 3
Recruiting NCT00441753 - Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest N/A
Completed NCT00347477 - Fluid Shifts in Patients Treated With Therapeutic Hypothermia After Cardiac Arrest Phase 3